Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micron Products
Atlanta, Georgia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Micron Biomedical has demonstrated in clinical and preclinical trials that its dissolvable microarray technology is at least as effective as injections for vaccines (measles, rubella, rotavirus, polio, influenza). The first-in-human trial for a rotavirus vaccine patch has been launched in partnership with Emory University. Its technology also shows promise for improving pediatric vaccine coverage and facilitating needle-free administration.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceVaccineBiologic
- Industry
- Biotech
02
Partnerships
Emory UniversityCenters for Disease Control and Prevention (CDC)CEPIBARDAZipcode Bio
Beyond the preview
Go deeper on Micron Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Micron Products.